# Methode Electronics Inc: financial statements, quarterly MEI · NYSE · CIK 65270 · [Technology](/sectors/technology.md) · fiscal year ends May 3 Pages: [Overview](/companies/mei.md) · [Financials](/companies/mei/financials.md) · [Filings](/companies/mei/filings.md) · [Insiders](/companies/mei/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mei/financials.md?period=annual). ## Income statement | Line item | Unit | Q2 FY2024 (2023-10-28) | Q3 FY2024 (2024-01-27) | Q4 FY2024 (2024-04-27) | Q1 FY2025 (2024-07-27) | Q2 FY2025 (2024-11-02) | Q3 FY2025 (2025-02-01) | Q4 FY2025 (2025-05-03) | Q1 FY2026 (2025-08-02) | Q2 FY2026 (2025-11-01) | Q3 FY2026 (2026-01-31) | Q4 FY2026 (2026-05-02) | Q1 FY2027 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [288](/filings/0000950170-24-133526.md) | [260](/filings/0000950170-25-033708.md) | [277 d](/filings/0000065270-26-000031.md) | [259](/filings/0000950170-25-113818.md) | [293](/filings/0000065270-25-000016.md) | [240](/filings/0000065270-26-000007.md) | [257 d](/filings/0000065270-26-000031.md) | [241](/filings/0000065270-26-000045.md) | [247](/filings/0000065270-25-000016.md) | [234](/filings/0000065270-26-000007.md) | [298 d](/filings/0000065270-26-000031.md) | [265](/filings/0000065270-26-000045.md) | | Cost of revenue | $m | [236](/filings/0000950170-24-133526.md) | [223](/filings/0000950170-25-033708.md) | [242 d](/filings/0000065270-26-000031.md) | [214](/filings/0000950170-25-113818.md) | [235](/filings/0000065270-25-000016.md) | [199](/filings/0000065270-26-000007.md) | [238 d](/filings/0000065270-26-000031.md) | [197](/filings/0000065270-26-000045.md) | [199](/filings/0000065270-25-000016.md) | [195](/filings/0000065270-26-000007.md) | [226 d](/filings/0000065270-26-000031.md) | [218](/filings/0000065270-26-000045.md) | | Gross profit | $m | [52.3](/filings/0000950170-24-133526.md) | [37.0](/filings/0000950170-25-033708.md) | [35.5 d](/filings/0000065270-26-000031.md) | [44.6](/filings/0000950170-25-113818.md) | [57.9](/filings/0000065270-25-000016.md) | [41.3](/filings/0000065270-26-000007.md) | [19.6 d](/filings/0000065270-26-000031.md) | [43.5](/filings/0000065270-26-000045.md) | [47.7](/filings/0000065270-25-000016.md) | [38.8](/filings/0000065270-26-000007.md) | [72.2 d](/filings/0000065270-26-000031.md) | [47.7](/filings/0000065270-26-000045.md) | | Selling, general and administrative | $m | [40.9](/filings/0000950170-24-133526.md) | [33.9](/filings/0000950170-25-033708.md) | [41.6 d](/filings/0000065270-26-000031.md) | [46.2](/filings/0000950170-25-113818.md) | [42.6](/filings/0000065270-25-000016.md) | [37.7](/filings/0000065270-26-000007.md) | [37.4 d](/filings/0000065270-26-000031.md) | [36.6](/filings/0000065270-26-000045.md) | [39.0](/filings/0000065270-25-000016.md) | [39.1](/filings/0000065270-26-000007.md) | [55.6 d](/filings/0000065270-26-000031.md) | [45.9](/filings/0000065270-26-000045.md) | | Operating income | $m | [(51.3)](/filings/0000950170-24-133526.md) | [(3.0)](/filings/0000950170-25-033708.md) | [(61.5) d](/filings/0000065270-26-000031.md) | [(7.5)](/filings/0000950170-25-113818.md) | [9.4](/filings/0000065270-25-000016.md) | [(2.2)](/filings/0000065270-26-000007.md) | [(23.6) d](/filings/0000065270-26-000031.md) | [1.1](/filings/0000065270-26-000045.md) | [2.9](/filings/0000065270-25-000016.md) | [(6.1)](/filings/0000065270-26-000007.md) | [10.9 d](/filings/0000065270-26-000031.md) | [(3.9)](/filings/0000065270-26-000045.md) | | Income tax | $m | [(0.2)](/filings/0000950170-24-133526.md) | [1.1](/filings/0000950170-25-033708.md) | [(5.8) d](/filings/0000065270-26-000031.md) | [5.2](/filings/0000950170-25-113818.md) | [3.2](/filings/0000065270-25-000016.md) | [6.2](/filings/0000065270-26-000007.md) | [(2.1) d](/filings/0000065270-26-000031.md) | [4.2](/filings/0000065270-26-000045.md) | [5.7](/filings/0000065270-25-000016.md) | [2.8](/filings/0000065270-26-000007.md) | [12.3 d](/filings/0000065270-26-000031.md) | [4.1](/filings/0000065270-26-000045.md) | | Net income | $m | [(55.3)](/filings/0000950170-24-133526.md) | [(11.6)](/filings/0000950170-25-033708.md) | [(57.3) d](/filings/0000065270-26-000031.md) | [(18.3)](/filings/0000950170-25-113818.md) | [(1.6)](/filings/0000065270-25-000016.md) | [(14.4)](/filings/0000065270-26-000007.md) | [(28.3) d](/filings/0000065270-26-000031.md) | [(10.3)](/filings/0000065270-26-000045.md) | [(9.9)](/filings/0000065270-25-000016.md) | [(15.9)](/filings/0000065270-26-000007.md) | [0.4 d](/filings/0000065270-26-000031.md) | [(11.4)](/filings/0000065270-26-000045.md) | | Diluted EPS | $ per share | [(1.55)](/filings/0000950170-24-133526.md) | [(0.33)](/filings/0000950170-25-033708.md) | not reported | [(0.52)](/filings/0000950170-25-113818.md) | [(0.05)](/filings/0000065270-25-000016.md) | [(0.41)](/filings/0000065270-26-000007.md) | not reported | [(0.29)](/filings/0000065270-26-000045.md) | [(0.28)](/filings/0000065270-25-000016.md) | [(0.45)](/filings/0000065270-26-000007.md) | not reported | [(0.32)](/filings/0000065270-26-000045.md) | | Basic EPS | $ per share | [(1.55)](/filings/0000950170-24-133526.md) | [(0.33)](/filings/0000950170-25-033708.md) | not reported | [(0.52)](/filings/0000950170-25-113818.md) | [(0.05)](/filings/0000065270-25-000016.md) | [(0.41)](/filings/0000065270-26-000007.md) | not reported | [(0.29)](/filings/0000065270-26-000045.md) | [(0.28)](/filings/0000065270-25-000016.md) | [(0.45)](/filings/0000065270-26-000007.md) | not reported | [(0.32)](/filings/0000065270-26-000045.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q2 FY2024 (2023-10-28) | Q3 FY2024 (2024-01-27) | FY2024 (2024-04-27) | Q1 FY2025 (2024-07-27) | Q2 FY2025 (2024-11-02) | Q3 FY2025 (2025-02-01) | FY2025 (2025-05-03) | Q1 FY2026 (2025-08-02) | Q2 FY2026 (2025-11-01) | Q3 FY2026 (2026-01-31) | FY2026 (2026-05-02) | Q1 FY2027 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [123](/filings/0000950170-23-068796.md) | [123](/filings/0000950170-24-027579.md) | [162](/filings/0000950170-25-094822.md) | [111](/filings/0000950170-24-103735.md) | [97.0](/filings/0000950170-24-133526.md) | [104](/filings/0000950170-25-033708.md) | [104](/filings/0000065270-26-000031.md) | [121](/filings/0000950170-25-113818.md) | [119](/filings/0000065270-25-000016.md) | [134](/filings/0000065270-26-000007.md) | [140](/filings/0000065270-26-000045.md) | [116](/filings/0000065270-26-000045.md) | | Current assets | $m | [637](/filings/0000950170-23-068796.md) | [630](/filings/0000950170-24-027579.md) | [638](/filings/0000950170-25-094822.md) | [612](/filings/0000950170-24-103735.md) | [613](/filings/0000950170-24-133526.md) | [572](/filings/0000950170-25-033708.md) | [560](/filings/0000065270-26-000031.md) | [549](/filings/0000950170-25-113818.md) | [555](/filings/0000065270-25-000016.md) | [585](/filings/0000065270-26-000007.md) | [600](/filings/0000065270-26-000045.md) | [584](/filings/0000065270-26-000045.md) | | Total assets | $m | [1,485](/filings/0000950170-23-068796.md) | [1,492](/filings/0000950170-24-027579.md) | [1,404](/filings/0000950170-25-094822.md) | [1,378](/filings/0000950170-24-103735.md) | [1,375](/filings/0000950170-24-133526.md) | [1,305](/filings/0000950170-25-033708.md) | [1,306](/filings/0000065270-26-000031.md) | [1,291](/filings/0000950170-25-113818.md) | [1,287](/filings/0000065270-25-000016.md) | [1,306](/filings/0000065270-26-000007.md) | [1,306](/filings/0000065270-26-000045.md) | [1,264](/filings/0000065270-26-000045.md) | | Current liabilities | $m | [218](/filings/0000950170-23-068796.md) | [230](/filings/0000950170-24-027579.md) | [231](/filings/0000950170-25-094822.md) | [261](/filings/0000950170-24-103735.md) | [223](/filings/0000950170-24-133526.md) | [201](/filings/0000950170-25-033708.md) | [233](/filings/0000065270-26-000031.md) | [220](/filings/0000950170-25-113818.md) | [218](/filings/0000065270-25-000016.md) | [243](/filings/0000065270-26-000007.md) | [254](/filings/0000065270-26-000045.md) | [242](/filings/0000065270-26-000045.md) | | Total liabilities | $m | [640](/filings/0000950170-23-068796.md) | [657](/filings/0000950170-24-027579.md) | [638](/filings/0000950170-25-094822.md) | [634](/filings/0000950170-24-103735.md) | [637](/filings/0000950170-24-133526.md) | [600](/filings/0000950170-25-033708.md) | [613](/filings/0000065270-26-000031.md) | [603](/filings/0000950170-25-113818.md) | [608](/filings/0000065270-25-000016.md) | [631](/filings/0000065270-26-000007.md) | [629](/filings/0000065270-26-000045.md) | [601](/filings/0000065270-26-000045.md) | | Long-term debt | $m | [329](/filings/0000950170-23-068796.md) | [331](/filings/0000950170-24-027579.md) | [331](/filings/0000950170-25-094822.md) | [296](/filings/0000950170-24-103735.md) | [340](/filings/0000950170-24-133526.md) | [328](/filings/0000950170-25-033708.md) | [317](/filings/0000065270-26-000031.md) | [323](/filings/0000950170-25-113818.md) | [332](/filings/0000065270-25-000016.md) | [341](/filings/0000065270-26-000007.md) | [325](/filings/0000065270-26-000045.md) | [310](/filings/0000065270-26-000045.md) | | Current portion of debt | $m | [3.0](/filings/0000950170-23-068796.md) | [0.2](/filings/0000950170-24-027579.md) | [0.2](/filings/0000950170-25-094822.md) | [0.2](/filings/0000950170-24-103735.md) | [0.2](/filings/0000950170-24-133526.md) | [0.2](/filings/0000950170-25-033708.md) | [0.2](/filings/0000065270-26-000031.md) | [0.2](/filings/0000950170-25-113818.md) | [0.2](/filings/0000065270-25-000016.md) | [0.2](/filings/0000065270-26-000007.md) | [0.2](/filings/0000065270-26-000045.md) | [0.2](/filings/0000065270-26-000045.md) | | Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [845](/filings/0000950170-25-033708.md) | [835](/filings/0000950170-25-033708.md) | [766](/filings/0000065270-26-000031.md) | [744](/filings/0000065270-25-000016.md) | [738](/filings/0000065270-26-000007.md) | [704](/filings/0000065270-26-000007.md) | [693](/filings/0000065270-26-000045.md) | [688](/filings/0000065270-26-000045.md) | [679](/filings/0000065270-26-000007.md) | [675](/filings/0000065270-26-000007.md) | [678](/filings/0000065270-26-000045.md) | [663](/filings/0000065270-26-000045.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Short-term borrowings: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q2 FY2024 (2023-10-28) | Q3 FY2024 (2024-01-27) | Q4 FY2024 (2024-04-27) | Q1 FY2025 (2024-07-27) | Q2 FY2025 (2024-11-02) | Q3 FY2025 (2025-02-01) | Q4 FY2025 (2025-05-03) | Q1 FY2026 (2025-08-02) | Q2 FY2026 (2025-11-01) | Q3 FY2026 (2026-01-31) | Q4 FY2026 (2026-05-02) | Q1 FY2027 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [(0.6) d](/filings/0000950170-24-133526.md) | [28.8 d](/filings/0000950170-25-033708.md) | [24.9 d](/filings/0000065270-26-000031.md) | [10.9](/filings/0000950170-25-113818.md) | [(48.0) d](/filings/0000065270-25-000016.md) | [28.1 d](/filings/0000065270-26-000007.md) | [35.4 d](/filings/0000065270-26-000031.md) | [25.1](/filings/0000065270-26-000045.md) | [(7.4) d](/filings/0000065270-25-000016.md) | [15.4 d](/filings/0000065270-26-000007.md) | [4.9 d](/filings/0000065270-26-000031.md) | [(7.8)](/filings/0000065270-26-000045.md) | | Capital expenditure | $m | [10.7 d](/filings/0000950170-24-133526.md) | [16.6 d](/filings/0000950170-25-033708.md) | [9.1 d](/filings/0000065270-26-000031.md) | [13.6](/filings/0000950170-25-113818.md) | [10.4 d](/filings/0000065270-25-000016.md) | [8.5 d](/filings/0000065270-26-000007.md) | [9.1 d](/filings/0000065270-26-000031.md) | [7.1](/filings/0000065270-26-000045.md) | [4.2 d](/filings/0000065270-25-000016.md) | [5.3 d](/filings/0000065270-26-000007.md) | [5.8 d](/filings/0000065270-26-000031.md) | [3.1](/filings/0000065270-26-000045.md) | | Dividends paid | $m | [4.8](/filings/0000950170-24-133526.md) | [4.9](/filings/0000950170-25-033708.md) | [4.9 d](/filings/0000065270-26-000031.md) | [5.1](/filings/0000950170-25-113818.md) | [4.9](/filings/0000065270-25-000016.md) | [5.3](/filings/0000065270-26-000007.md) | [5.1 d](/filings/0000065270-26-000031.md) | [2.8](/filings/0000065270-26-000045.md) | [1.9](/filings/0000065270-25-000016.md) | [1.8](/filings/0000065270-26-000007.md) | [1.8 d](/filings/0000065270-26-000031.md) | [1.8](/filings/0000065270-26-000045.md) | | Share repurchases | $m | not reported | [3.0 d](/filings/0000950170-25-033708.md) | [2.9 d](/filings/0000065270-26-000031.md) | [1.6](/filings/0000950170-25-113818.md) | [0.0 d](/filings/0000065270-25-000016.md) | [0.0 d](/filings/0000065270-26-000007.md) | [0.0 d](/filings/0000065270-26-000031.md) | [0.0](/filings/0000950170-25-113818.md) | [0.0 d](/filings/0000065270-25-000016.md) | [0.0 d](/filings/0000065270-26-000007.md) | [0.0 d](/filings/0000065270-26-000031.md) | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividendsCommonStock - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q2 FY2023 (2022-10-29) | Q3 FY2023 (2023-01-28) | Q1 FY2024 (2023-07-29) | Q2 FY2024 (2023-10-28) | Q3 FY2024 (2024-01-27) | Q1 FY2025 (2024-07-27) | Q2 FY2025 (2024-11-02) | Q3 FY2025 (2025-02-01) | Q1 FY2026 (2025-08-02) | Q2 FY2026 (2025-11-01) | Q3 FY2026 (2026-01-31) | Q1 FY2027 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [36.8](/filings/0000950170-23-068796.md) | [36.6](/filings/0000950170-24-027579.md) | [36.3](/filings/0000950170-24-103735.md) | [35.7](/filings/0000950170-24-133526.md) | [35.3](/filings/0000950170-25-033708.md) | [35.4](/filings/0000950170-25-113818.md) | [35.5](/filings/0000065270-25-000016.md) | [35.2](/filings/0000065270-26-000007.md) | [35.4](/filings/0000065270-26-000045.md) | [35.5](/filings/0000065270-25-000016.md) | [35.6](/filings/0000065270-26-000007.md) | [35.7](/filings/0000065270-26-000045.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 35,645,053 at 2026-08-31, from the cover of the [10-Q filed 2026-09-02](/filings/0000065270-26-000045.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.